Key Point:
• Neutrophils of FHL-5 patients with munc18-2/STXBP2 mutations have impaired granule fusion and bacterial killing Abstract:
Familial hemophagocytic lymphohistiocytosis (FHL) is caused by genetic defects in cytotoxic granule components or their fusion machinery, leading to impaired Natural Killer (NK) cell and/or T lymphocyte (CTL) degranulation and/or cytotoxicity. This may accumulate into a life-threatening condition known as macrophage activation syndrome.
STXBP2, also known as MUNC18-2, has recently been identified as the disease-causing gene in FHL5. A role for STXBP2 in neutrophils, and for neutrophils in FHL in general, has not been documented thus far. Here, we report that FHL5 neutrophils have a profound defect in granule mobilization, resulting in inadequate bacterial killing, in particular of Gram-negative Escherichia coli, but not of Staphylococcus aureus, which rather depends on intact NADPH oxidase activity. This impairment of bacterial killing may contribute to the apparent susceptibility to gastrointestinal inflammation in FHL5 patients.
Introduction
Rare mutations (incidence: ~1-4 cases/million depending on ethnicity) in four different genes, including PRF1 (encoding perforin-1) in FHL2, UNC13D (encoding Munc13-4) in FHL3, STX11 (encoding syntaxin 11) in FHL4, and, more recently, also STXBP2 (also known as MUNC18-2), encoding the granule-associated docking protein syntaxin binding protein 2 (STXBP2), in FHL5, have been identified as disease-causing in FHL patients [1] [2] [3] . FHL-5 accounts for an estimated 10% of all FHL cases. STXBP2 is important for regulating intracellular granule trafficking and docking at the plasma membrane.
Previous reports have documented the role of STXBP2 in NK, CTL and platelet degranulation in FHL type 5 patients (FHL-5) [2] [3] [4] . Some of the clinical features of FHL5, such as the increased susceptibility to gastrointestinal bacterial infection 5 , have remained unexplained and it therefore seems possible that STXBP2 plays a role in other leukocytes, such as neutrophils. Indeed, STXBP2 has been reported to localize to the different types of granules in human neutrophils 6, 7 . Neutrophil granules contain an array of anti-microbial constituents and proteases that will be secreted and/or released into the phagosome upon mobilization and this process contributes to microbial killing. Although there is some evidence for an involvement of STXBP2 in neutrophil granule function 7 , compelling evidence for a direct role has not been documented. Here, we demonstrate that STXBP2 is involved in neutrophil granule mobilization and bacterial killing using neutrophils from three genetically-defined FHL5 patients.
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Materials and methods

FHL5 patients, control subjects and neutrophil isolation
Heparinized blood was collected, after informed consent and according to the declaration of Helsinki 1964, from three unrelated FHL-5 patients (supplementary table 1) and healthy controls, which included umbilical cord blood and blood from healthy adults.
Granulocytes were isolated by density gradient centrifugation with isotonic Percoll (Pharmacia, Uppsala, Sweden) and erythrocyte lysis, as described before. 8 
Degranulation assays
Neutrophil degranulation was examined as described before. 9 Briefly, neutrophils (2×10 6 /ml) were incubated in Hepes-buffered saline solution (Hepes-buffer) at 37ºC in a shaking water bath before adding the (priming) agents PAF (1 
Bacterial killing
Granulocyte bactericidal activity was determined using, Escherichia coli, strain ML-35, and Staphylococcus aureus, strain 502A. Bacterial survival was measured by assaying bacterial colony formation as previously described 10 .
Statistics
Statistical significance was determined where possible using Students t-test, or otherwise by Grubb's outlier test; p≤0.05 was considered to be significant.
Results and discussion
In order to characterize a role for STXBP2 in neutrophil function and a possible contribution of neutrophils to FHL5, we analyzed three unrelated patients with defined mutations in STXBP-2 (Suppl. Table 1 ). The absence of STXBP2 protein in neutrophils of patients A and C was confirmed by Western blot analysis, whereas patient B carrying a homozygous exon 15 splice site mutation, which is known to be associated with residual NK function and a milder clinical phenotype 11 , did express substantial levels of a STXBP2 protein (Suppl. Fig.1A ). As reported before 12 , this splice site mutation yields a variant STXBP2 protein (Suppl. Fig.1B ), most likely with a partially impaired function. In line with this, and also with previous findings 11 , a complete (patients A and C) or partial (patient B) absence of NK cell-mediated degranulation and cytotoxicity towards target cells was observed (Suppl. Fig.2 ). The exocytosis of the different types of neutrophil granules 6 , induced by either cytochalasin-B/fMLP or PAF/fMLP, was evaluated by monitoring secretion of the granule components elastase (azurophilic granules) or lactoferrin (LAF) (specific granules) and the exposure of cell surface CD63 (azurophilic granules) or CD66b (secretory, tertiary and specific granules) ( Fig.1 ). This revealed a pronounced defect in the release of both types of vesicles in FHL5 neutrophils of all three patients. Consistently, the cytoB/fMLP-stimulated release of extracellular proteolytic activity, analyzed by DQ-BSA proteolysis assay, which primarily measures neutrophilderived serine proteases, appeared completely absent in FHL5 neutrophils, although the total cellular content of the proteases was not different (Suppl. Fig.3 ). Immuno-EM analysis of the tertiary, specific and azurophilic granules, using respectively gelatinase, lactoferrin and MPO as markers, showed a normal granule appearances and frequencies For personal use only. on October 31, 2017. by guest www.bloodjournal.org From (Suppl. Fig.4 ), thereby excluding defects in granule biosynthesis. Measurement of intraphagosomal serine protease activity suggested that mobilization of neutrophil granules to phagosomes was also substantially impaired in FHL-5 neutrophils (Suppl. Fig.5 ), although it was certainly not completely absent as also shown by the presence of both specific and azurophilic granule components in E.coli-containing phagosomes (Suppl. Fig.6 ). Collectively, these findings suggested, for the first time, that STXBP2 is required for neutrophil granule exocytosis, and likewise also, at least in part, for granule mobilization to the phagosome.
Neutrophils are essential for controlling bacterial and fungal infections. There are two mechanisms that primarily contribute to neutrophil-mediated killing of microbes: (a) the NADPH oxidase, which upon assembly and activation in the phagosomal-and/or plasma-membrane produces toxic reactive oxygen species, and (b) proteolytic killing, which is assumed to require the fusion of the protease-loaded azurophilic granules with phagosomal-and/or plasma-membrane. Although gene targeting experiments in the mouse have demonstrated that both mechanisms may act independently or in concert to achieve full destructive power, the relative contribution of each activity depends on the nature of the microbe as well. [13] [14] [15] However, in spite of abundant information on neutrophil microbial killing in a human context with respect to the role of the NADPH oxidase, an activity that is defective in chronic granulomatous disease (CGD), much less is know about the contribution of granule mobilization in human neutrophils. Clearly, the availability of FHL5 neutrophils with a granule mobilization defect allowed us to explore this directly.
Neutrophil-mediated killing of S. aureus and E. coli was evaluated. Figure 2 shows that For personal use only. on October 31, 2017. by guest www.bloodjournal.org From the S. aureus killing was virtually unaffected in FHL5 neutrophils, but the killing of E. coli was substantially impaired in cells from all patients investigated. Of relevance, the phagocytosis of the bacteria was apparently not significantly affected (Suppl. Fig.7) . In line with a complementary role for the NADPH oxidase in this context, S. aureus killing was more or less abolished in cells treated with the NADPH oxidase inhibitor diphenylene iodonium (DPI), while the killing of E. coli was only partially impaired (Suppl. Fig.8 ). Similar abnormalities in killing have been observed with neutrophils from CGD patients 16 (and data not shown). It should be noted that the production of reactive oxygen species by the NADPH oxidase in response to particulate stimuli, such as unopsonized or opsonized zymosan (Suppl. Fig.9A ), or soluble stimuli, such as PAF/fMLP (not shown), was not impaired in FHL5 neutrophils. However, the intraphagosomal oxidation of DHR-coated E.coli appeared slightly delayed in FHL-5 neutrophils (Suppl. Fig.9B ). Because DHR oxidation requires MPO activity 17 this is consistent with the impaired mobilization of granules to phagosomes noted above.
Collectively, these findings suggest that, while S. aureus killing depends primarily on the NADPH oxidase, both the oxidase as well as granule mobilization-dependent mechanisms, either to the plasma membrane and/or to the phagosomal membrane, play a role in E. coli killing. Finally, chemotaxis of FHL5 neutrophils was apparently normal (Suppl. Fig.10 ).
Taken together, to our knowledge these findings provide the first direct demonstration of a requirement for STXBP2 in particular, and granule mobilization in general, in the killing of bacteria by human neutrophils. This defect in bacterial killing may potentially also explain some of the unexplained symptoms, such as the increased For personal use only. on October 31, 2017. by guest www.bloodjournal.org From susceptibility to gastrointestinal inflammation, which has previously been reported in FHL5 patients 5 .
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